Trial site
Hospital Universitario de Basurto
Bilbao, Vizcaya 48013, SpainNot linked to an institution yet
- 16running trials
- 4closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Phase
- Phase 36 trials
- Phase 23 trials
- Phase 42 trials
- Status
- Recruiting9 trials
- Active, not recruiting6 trials
- Completed4 trials
- Not yet recruiting1 trial
- Lead sponsor
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company2 trials
- PETHEMA Foundation2 trials
- AgNovos Healthcare, LLC1 trial
- ALX Oncology Inc.1 trial
- Amgen1 trial
- and 13 more
Running trials
Recruiting
A Phase 3 Study of INCA033989 Versus Best Available Therapy in Participants With Essential Thrombocythemia
NCT07623200· Phase 3· Incyte Corporation· Source
Recruiting
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
NCT07007559· Phase 2· ALX Oncology Inc.· Source
Contact: Cheng Quah, MD
Recruiting
Efficacy of Plasma Rich in Growth Factors (PRGF) in the Treatment of Foot Ulcers in Diabetic Patients With Peripheral Arterial Disease
NCT06952998· Phase 4· Biotechnology Institute IMASD· Source
Contact: Arkaitz Lara
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
NCT07207811· Phase 3· Novo Nordisk A/S· Source
Contact: Novo Nordisk
Recruiting
Response-adaptive to Epcoritamab In First Relapse: Study to Evaluate the Efficacy of Eptoritamab in Patients With Relapse/Refractory Large B Cell Lymphoma
NCT07126236· Phase 2· Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea· Source
Contact: Cristina Barrenetxea
Active, not recruiting
POWER AUDIT, Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol After Gastric Surgery (POWER 4 + 3)
NCT06790238· Grupo Español de Rehabilitación Multimodal· Source
Recruiting
Immunological Characteristics of Preclinical IBD
NCT05698745· Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa· Source
Contact: Jone Ortíz de Zarate, MD
Recruiting
Reduction of the Incidence of NAV in Neonatal Units (INBERNAV-Neo)
NCT07240038· Biobizkaia Health Research Institute· Source
Contact: Ainhoa Aguirre Conde
Active, not recruiting
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State
NCT06245408· Phase 3· Amgen· Source
Recruiting
DESTINY Breast Respond HER2-(Ultra)Low Europe
NCT05945732· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source
Recruiting
AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)
NCT05890716· Idoven 1903 S.L.· Source
Contact: Alain García Olea, MD
Active, not recruiting
Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)
NCT05024773· Phase 3· Fidia Farmaceutici s.p.a.· Source
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NCT04796350· AgNovos Healthcare, LLC· Source
Contact: RESTORE Study
Active, not recruiting
Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia
NCT04579367· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source
Active, not recruiting
Study to Compare Azacitidine Plus Pevonedistat Versus Azacitidine in Patients With Acute Myeloid Leukemia Not Eligible for Standard Chemotherapy
NCT04090736· Phase 3· PETHEMA Foundation· Source
Recruiting
A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
NCT02819882· Spanish Breast Cancer Research Group· Source
Contact: MS Study Project Manager
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error